SN3
SHORT NOTE
5M
★ High-yield
Describe allosteric enzymes with their characteristics and examples. Add a note on feedback inhibition.
Definition
Allosteric enzymes = regulatory enzymes whose activity is altered by the non-covalent binding of a modulator at a site other than the active site.
- Usually the rate-limiting enzyme of a pathway, catalysing the first committed and irreversible step
Characteristics
- Oligomeric — several subunits, each with an active site and a regulatory (allosteric) site
- Sigmoid (S-shaped) kinetics, not the hyperbola of Michaelis–Menten
- Show co-operativity — binding at one site changes the affinity of the others
- The measure of affinity is K0.5, not Km
- Sensitive to small changes in modulator concentration — the sigmoid shape means a small rise produces a large change in rate
- Modulators may be homotropic (the substrate itself) or heterotropic (a different molecule)
Models of Allosteric Behaviour
| Model | Proposed by | Concept |
|---|---|---|
| Concerted (symmetry) | Monod, Wyman, Changeux | All subunits switch together between a T (tense, low affinity) and R (relaxed, high affinity) state |
| Sequential | Koshland | Subunits change one at a time, each influencing the next |
Important Examples
| Enzyme | Pathway | Positive modulator | Negative modulator |
|---|---|---|---|
| Phosphofructokinase-1 | Glycolysis | Amp, fructose-2,6-bisphosphate | ATP, citrate |
| Aspartate transcarbamoylase | Pyrimidine synthesis | ATP | CTP (feedback) |
| Isocitrate dehydrogenase | TCA cycle | ADP | ATP, NADH |
| HMG-CoA reductase | Cholesterol synthesis | — | Cholesterol |
| Carbamoyl phosphate synthetase I | Urea cycle | N-acetylglutamate | — |
| Acetyl-CoA carboxylase | Fatty acid synthesis | Citrate | Palmitoyl-CoA |
Feedback Inhibition
A → Enzyme 1 (allosteric, rate-limiting) → B → C → End product D → D inhibits Enzyme 1
- Also called end-product or retro-inhibition
- Prevents wasteful overproduction — the commonest physiological control of a pathway
- Acts on the first committed step, so no intermediates accumulate
Applied Aspects
- Haemoglobin is the classic allosteric protein — sigmoid oxygen curve, T and R states, with 2,3-BPG, H+ and CO2 as negative modulators. It is not an enzyme but obeys the same principles
- Allosteric drugs — benzodiazepines act at an allosteric site on the GABAA receptor
- Loss of feedback inhibition underlies some metabolic disease — in acute intermittent porphyria, reduced haem fails to inhibit ala synthase, so precursors accumulate
All questions in Enzymes
- Q1Define enzymes. Classify them according to the IUBMB system and describe the mechanism of enzyme action. Add a note on enzyme specificity. ★
- Q2Describe the effect of substrate concentration on enzyme activity. Explain the Michaelis–Menten equation, the significance of Km and the Lineweaver–Burk plot. ★
- Q3Classify enzyme inhibition. Describe competitive, non-competitive and uncompetitive inhibition with their effects on Km and Vmax, and give examples. ★
- Q4Describe the mechanisms regulating enzyme activity. Explain allosteric regulation, covalent modification and enzyme induction with examples. ★
- Q5Describe the diagnostic importance of serum enzymes. Give the enzyme profile in myocardial infarction and liver disease. Add a note on isoenzymes. ★
- SN1Define coenzymes. Enumerate the coenzymes derived from vitamins with their functions. ★
- SN2Define isoenzymes. Describe the isoenzymes of lactate dehydrogenase and creatine kinase with their clinical significance. ★
- SN3Describe allosteric enzymes with their characteristics and examples. Add a note on feedback inhibition. ★
- SN4Define zymogens. Give examples and explain their physiological importance. ★
- SN5Define Km. Describe its significance with the example of hexokinase and glucokinase. ★
- SN6Describe competitive inhibition with its characteristics and medically important examples. ★
- SN7Describe the types of enzyme specificity with examples.